Consumer
The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications.
Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.
The Series E funding comes four months after the company secured $250 million in a Series D round.
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
HIMSS25
Dr. Sarah Hoffe, interim GI oncology chair at Moffitt Cancer Center, says telemedicine platforms and other technologies help ease nurse burnout, boost patient adherence and enable focused, personalized patient connections.
The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.